Activist 13D/13G Filings - SR ONE CAPITAL MANAGEMENT LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-09-23
8:56 pm
Purchase
13DZENAS BIOPHARMA INC
ZBIO
SR ONE CAPITAL MANAGEMENT LLC4,911,539
12.300%
4,911,539increase
(New Position)
View
2024-07-08
8:54 pm
Purchase
13DKALA BIO, INC.
KALA
SR ONE CAPITAL MANAGEMENT LLC445,643
9.990%
445,643increase
(New Position)
View
2024-03-25
6:41 pm
Sale
13DArcellx Inc.
ACLX
SR ONE CAPITAL MANAGEMENT LLC2,346,630
4.440%
-800,000decrease
(-25.42%)
View
2024-02-09
8:14 pm
Sale
13GEFFECTOR THERAPEUTICS INC
EFTR
SR ONE CAPITAL MANAGEMENT LLC0
0.000%
-6,822,114decrease
(Position Closed)
View
2023-12-18
4:16 pm
Sale
13DArcellx Inc.
ACLX
SR ONE CAPITAL MANAGEMENT LLC3,146,630
6.460%
-800,000decrease
(-20.27%)
View
2023-06-02
4:46 pm
Sale
13DArcellx Inc.
ACLX
SR ONE CAPITAL MANAGEMENT LLC3,946,630
8.220%
-540,544decrease
(-12.05%)
View
2023-05-19
5:02 pm
Sale
13DArcellx Inc.
ACLX
SR ONE CAPITAL MANAGEMENT LLC4,487,174
9.350%
-1,012,833decrease
(-18.42%)
View
2022-06-27
4:35 pm
Unchanged
13DArcellx Inc.
ACLX
SR ONE CAPITAL MANAGEMENT LLC5,500,007
12.900%
0
(Unchanged)
View
2022-02-17
12:46 pm
Purchase
13DArcellx Inc.
ACLX
SR ONE CAPITAL MANAGEMENT LLC5,500,007
15.800%
5,500,007increase
(New Position)
View
2022-02-11
8:35 pm
Purchase
13GEFFECTOR THERAPEUTICS INC
EFTR
SR ONE CAPITAL MANAGEMENT LLC6,822,114
16.900%
6,822,114increase
(New Position)
View